Macrolides in the respiratory tract in cystic fibrosis.
Jaffé
Adam
A
Department of Respiratory Medicine, Great Ormond Street Hospital for Children NHS Trust, UK.
Rosenthal
Mark
M
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001422:Bacterial Adhesion; D018441:Biofilms / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D003550:Cystic Fibrosis / Q000150:complications*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism; D018942:Macrolides; D009504:Neutrophils / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000209:etiology; D013183:Sputum / Q000187:drug effects; D014783:Viscosity
D000900:Anti-Bacterial Agents; D016209:Interleukin-8; D018942:Macrolides